Paz Says Express Scripts' Caremark Offer Has `Superior Value'
Jan. 16 (Bloomberg) -- George Paz, chief executive officer of Express Scripts Inc., speaks on a teleconference about the company's hostile exchange offer for Caremark Rx Inc. Express Scripts initiated an exchange offer for all shares outstanding of Caremark Rx Inc., seeking to push its $24.3 billion hostile bid past a $22.3 billion takeover offer from CVS Corp. Express Scripts' unsolicited offer was rejected last week by Caremark's board. Buying Caremark would make Express Scripts, based in Maryland Heights, Missouri, the largest manager of drug benefits in the U.S. David Myers also speaks. (Source: Express Scripts Inc.)
00:00 Myers: introductions and safe harbor clause 01:46 Myers: proxy statements 04:20 Paz: "superior value" of offer for Caremark 13:30 Paz: business model and cost savings 15:57 Paz: conflicts of CVS's bid for Caremark 17:49 Paz: differences in business models, clients 24:17 Paz: 2007 growth outlook for Express Scripts 25:22 Paz: "strength" of Express Scripts bid 26:38 Questions: Paz on regulatory approval 29:36 Paz: negotiations with Caremark 31:52 Paz: details of the exchange offer; filing 32:53 Paz: vertical vs. horizontal business models 37:44 Paz: role of Express Scripts shareholders 40:11 Paz: due diligence; integration strategy 43:03 Paz: Express Scripts "well positioned" for deal
Running time 44:04
Last Updated: January 16, 2007 12:39 EST
HOME